Is there any doubt that your pharma business can save a lot of money by opting for third-party manufacturing? Many companies use this model to cut down production costs without establishing their own plant. Rather than spending a lot of money on land, as well as machines, production operators, quality systems and routine maintenance, companies may collaborate with a seasoned manufacturer. But the saving is dependent on the volume of the product and packaging, formulation, quality requirements, and manufacturing terms. Businesses should carefully compare to learn about the savings. This blog outlines the primary costs involved and demonstrates how third-party pharma manufacturing can help with improved financial planning.
Understanding Third-Party Pharma Manufacturing
Third-party pharma manufacturing refers to a medical firm obtaining medicines manufactured by another licensed manufacturing firm. Production is undertaken by the partner to agreed specifications. The brand owner can concentrate on the product planning, marketing, distribution and sales.
The primary benefit is the cost savings from the lack of investment to create and run a manufacturing plant. You don’t have to buy production equipment, construct the manufacturing spaces or hire a full factory staff.
Where Do the Savings Come From?
First of all, there is a reduction in infrastructure investments. Establishment of a pharmaceutical manufacturing plant demands a lot of investment. Enterprises require appropriate premises, production equipment, storage space, quality control facilities and auxiliary facilities.
When the product is made by a third party, this changes the cost structure. The business only pays the manufacturing partner for the specified production tasks instead of paying for the full facility. This can free up capital that is invested in manufacturing equipment.
Savings on Machinery and Maintenance
The maintenance, calibration, repair and upgrading of pharma manufacturing equipment are regular tasks. These costs are in addition to the ownership costs of the facilities.
In third-party manufacturing, the manufacturing partner will typically oversee the manufacturing equipment and related manufacturing operation requirements. This means that the brand owner is spared numerous direct costs of equipment ownership. This can help to simplify budgeting for companies that are not manufacturing medicines in bulk quantities.
Lower Labour and Operational Costs
There are trained production workers, quality professionals, maintenance workers, supervisors and other employees who are needed to run a manufacturing plant. The companies also have to deal with the utilities, safety systems, cleaning and everyday activities.
Third-party manufacturing reduces these direct operating liabilities. The workforce and production are ready for the agreed products and are already in place at the manufacturer. This enables the pharma company to not develop a manufacturing team.
Reduced Production Overheads
Other production costs include electricity, water, storage, production planning, quality testing, etc. These costs are borne directly by the company if it has its own facility.
A third-party manufacturer can distribute these costs over production orders. This can enhance efficiency. But companies must determine the total manufacturing cost quoted and see whether the manufacturing cost they would have internally was lower or not before making any assumption about the cost saving.
Better Cost Control for Different Volumes
The financial benefit is very sensitive to the volume of production. If a company has a small or variable demand, it may be more viable to have third-party manufacturing than to have a factory that is not being used to its potential.
A business may not want to have a large batch of a medicine made, but having a production facility dedicated specifically to that medicine might not be cost-effective. A manufacturing partner can manufacture the required quantity in accordance with the agreed terms. This enables the company to better align the costs of manufacturing with the actual demand.
Savings Through Existing Expertise
Successful manufacturers have proven processes, trained staff, quality systems, and supplier networks. Developing these skills in-house can be a costly and time-consuming endeavour.
A company may utilise the manufacturing partnership to leverage existing capabilities and avoid building everything from scratch. This can decrease setup costs and help the business to commence production earlier.
How to Calculate Potential Savings?
The price of the quotation should not be the sole basis for making a judgement on a business’s savings. All costs associated with in-house production should be taken into account in a proper calculation.
These should comprise of factory setup, equipment, employee wages and benefits, utilities, maintenance, quality testing, storage, compliance activities and other operating costs incurred by the company. They should then make a comparison with the quotation and expense for third-party manufacturing.
Order quantity, packaging needs, product specifications and transportation costs should also be taken into account when computing. These factors can make the ending price vary considerably.
What Can Affect Your Actual Savings?
Saving doesn’t always translate to the same savings for every business when using third-party manufacturing. Manufacturing costs may be influenced by product complexity. The quotation can be higher due to special formulations, packaging materials, test specifications and order quantities.
The final expense may also be impacted by transportation and storage. The business needs to evaluate all the terms and conditions to choose the right manufacturing partner.
Quality and compliance are also important. A lower bid may not be worth it if not of an acceptable quality. It is therefore important for companies to compare the cost and manufacturing capability, documentation, quality systems and reliability.
Is Third-Party Manufacturing More Cost-Effective?
Today third-party manufacturing is a viable alternative to investing in a manufacturing plant for many companies. It can decrease the capital investment and the direct responsibilities of several operational tasks.
The best advantage is typically when enterprises would like to introduce new products without spending much on manufacturing facilities. It can also assist companies to adjust their production as per the requirements.
But it’s important to make the decision based on real quotes and full cost comparisons. This is determined by the product’s needs, the production volume, business objectives, and production partner conditions.
Conclusion
Third-party pharma manufacturing can decrease in-factory operating costs and equipment expenditures, as well as the requirement for large investments in infrastructure, equipment and ownership. It can also aid the business in managing the production costs as per demand. But savings are different depending on the product and order quantities. A detailed cost comparison provides a more precise description of the benefit. You can consider Torainse Lifecare’s business support for manufacturing.
